keyword
https://read.qxmd.com/read/38614259/antitumoral-activity-of-different-amaryllidaceae-alkaloids-in-vitro-and-in-silico-assays
#1
JOURNAL ARTICLE
Luciana R Tallini, Gustavo Machado das Neves, Maria Helena Vendruscolo, Paula Rezende-Teixeira, Warley Borges, Jaume Bastida, Letícia V Costa-Lotufo, Vera Lucia Eifler-Lima, José Angelo S Zuanazzi
ETHNOPHARMACOLOGY RELEVANCE: The plants of Amaryllidaceae family, such as Amaryllis belladonna L., have been used as herbal remedies for thousands of years to address various disorders, including diseases that might today be identified as cancer. AIM OF THE STUDY: The objective of this work was to evaluate the potential of three Amaryllidaceae alkaloids against four cancer cell lines. MATERIAL AND METHODS: The alkaloids lycorine, 1-O-acetylcaranine, and montanine were evaluated in vitro against colon adenocarcinoma cell line (HCT-116) and breast carcinoma cell lines (MCF-7, MDAMB231, and Hs578T)...
April 11, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38612711/pfdn4-as-a-prognostic-marker-was-associated-with-chemotherapy-resistance-through-crebp1-aurka-pathway-in-triple-negative-breast-cancer
#2
JOURNAL ARTICLE
Shih-Ho Wang, Cheng-Hsi Yeh, Chia-Wei Wu, Chia-Yi Hsu, Eing-Mei Tsai, Chao-Ming Hung, Yi-Wen Wang, Tsung-Hua Hsieh
Breast cancer is the most common malignancy and its incidence is increasing. It is currently mainly treated by clinical chemotherapy, but chemoresistance remains poorly understood. Prefolded proteins 4 (PFDN4) are molecular chaperone complexes that bind to newly synthesized polypeptides and allow them to fold correctly to stabilize protein formation. This study aimed to investigate the role of PFDN4 in chemotherapy resistance in breast cancer. Our study found that PFDN4 was highly expressed in breast cancer compared to normal tissues and was statistically significantly associated with stage, nodal status, subclasses (luminal, HER2 positive and triple negative), triple-negative subtype and disease-specific survival by TCGA database analysis...
March 31, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38430025/combination-therapy-application-of-abemaciclib-with-doxorubicin-in-triple-negative-breast-cancer-cell-line-mda-mb-231
#3
JOURNAL ARTICLE
Tugce Nur Eralp, Akin Sevinc, Banu Mansuroglu
Due to lack of clinical biomarkers, Triple Negative Breast Cancer (TNBC) is more likely to have spread to other tissues at time of diagnosis and therapy planning generally involves use of cytotoxic chemotherapy agents, such as Doxorubicin. We aimed to investigate possible advantages of using combination strategy using Doxorubicin alongside Abemaciclib. After determining the IC50 values for Doxorubicin (DOX) and Abemaciclib (ABE); CompuSyn and ComBenefit software were used to reveal the effect resulting from the combination of two drugs...
February 29, 2024: Cellular and Molecular Biology
https://read.qxmd.com/read/38291201/influence-of-copper-i-nicotinate-complex-on-the-notch1-signaling-pathway-in-triple-negative-breast-cancer-cell-lines
#4
JOURNAL ARTICLE
Mohamed A Abdel-Mohsen, Asmaa M Badawy, Morsy A Abu-Youssef, Mona A Yehia, Lobna D Abou Shamaa, Shymaa A Abdullah
Triple negative breast cancer (TNBC) is a subtype of breast cancer which is characterized by its aggressiveness, poor and short overall survival. In this concept, there is a growing demand for metal-based compounds in TNBC therapy as copper complex that have a less toxic effect on normal cells and could stimulate apoptotic cell death. Additionally, Notch1 signaling pathway has received great attention as one of the most important potential targets for developing a novel therapeutic strategy. The present study is an attempt to assess the promising chemotherapeutic activities of copper(I) nicotinate (CNC) through its impact on the expression of downstream genes of Notch1 signaling pathway and the cell fate of TNBC...
January 30, 2024: Scientific Reports
https://read.qxmd.com/read/38202350/anticancer-immunomodulatory-and-phytochemical-screening-of-carthamus-oxyacantha-m-bieb-growing-in-the-north-of-iraq
#5
JOURNAL ARTICLE
Media Mohammad Baban, Saman A Ahmad, Ala' M Abu-Odeh, Mustafa Baban, Wamidh H Talib
Carthamus oxyacantha M.Bieb is a promising repository of active phytochemicals. These bioactive compounds work synergistically to promote the plant's antioxidant, anticancer, and immunomodulatory capabilities. The present study aimed to discover the potential immunomodulatory and cytotoxicity of different extracts of Carthamus oxycantha roots. Aqueous ethanol (70%), aqueous methanol (90%), ethyl acetate, and n-hexane extracts were tested against five cell lines (T47D, MDA-MB231, Caco-2, EMT6/P, and Vero). Among these extracts, ethyl acetate and n-hexane extracts showed significant activity in inhibiting the proliferation of cancerous cells because of the presence of several phytochemical compounds, including flavonoids, phenolics, and alkaloids...
December 22, 2023: Plants (Basel, Switzerland)
https://read.qxmd.com/read/37509107/chemically-modified-sepharose-6b-beads-for-collection-of-circulating-tumor-cells
#6
JOURNAL ARTICLE
Haiyan Chen, Yiming Zhang, Xiaoxiao Ma, Bohao Zhou, Zhonghua Liu
The isolation and quantitative characterization of circulating tumor cells (CTCs) are of great importance in cancer diagnosis and prognosis. However, isolating and detecting CTCs in whole blood presents a significant challenge due to the low numbers of CTCs (often ranging from one to five) in samples containing billions of erythrocytes. Recently, point-of-care devices that use antibody trapping coupled with remote immunofluorescence analyses have been described to identify the number and type of CTCs in blood...
July 3, 2023: Biomolecules
https://read.qxmd.com/read/37483239/imine-linked-covalent-organic-frameworks-a-biocompatible-and-ph-dependent-carrier-for-in-vitro-sustained-release-of-doxorubicin
#7
JOURNAL ARTICLE
Nazanin Mokhtari, Mohammad Dinari, Fatemeh Khosravi Esmaeiltarkhani
Among the novel drug delivery systems (DDSs), covalent organic frameworks (COFs) show promising features in pharmaceutical science. In this paper, an imine-linked COF with hexagonal topology was synthesized using the autoclave condition. Then, the prepared COF (APB-COF) was used as a pH-dependent carrier for in vitro release of doxorubicin (DOX). The intrinsic properties of APB-COF caused reaching an excellent drug encapsulation efficiency. DOX@APB-COF shows an exemplary pH-dependent release in two different pHs...
July 18, 2023: ACS Omega
https://read.qxmd.com/read/36668683/novel-her2-targeted-peptide-for-nir-ii-imaging-of-tumor
#8
JOURNAL ARTICLE
Rui Cao, Renda Li, Hui Shi, Hongguang Liu, Zhen Cheng
Molecular targets serve a crucial role in drug development. Herein, we discovered a novel peptide that can specifically target the human epidermal growth factor receptor 2 (HER2) and thus named it Herceptide. In our study, Herceptide was conjugated to the near-infrared fluorescent dye indocyanine green (ICG) to obtain a probe, ICG-Herceptide. Importantly, specific binding to HER2 was revealed by molecular docking, surface plasmon resonance analysis, and competition assays. The probe showed high binding affinity ( K D = 1...
January 20, 2023: Molecular Pharmaceutics
https://read.qxmd.com/read/36513925/visualizing-activated-myofibroblasts-resulting-from-differentiation-of-mesenchymal-stem-cells
#9
JOURNAL ARTICLE
Pravin J Mishra, Debabrata Banerjee
Mesenchymal stem cells (MSCs) are multipotent cells that exhibit two main characteristics which define stem cells: self-renewal and differentiation. MSCs can migrate to sites of injury, inflammation, and tumor. Moreover, MSCs undergo myofibroblast-like differentiation, including increased production of α-SMA in response to transforming growth factor-β (TGF-β), a growth factor commonly secreted by tumor cells to evade immune surveillance. Based on our previous findings, hMSCs become activated and resemble carcinoma-associated myofibroblasts upon prolonged exposure to a conditioned medium from MDAMB231 human breast cancer cells...
2023: Methods in Molecular Biology
https://read.qxmd.com/read/36328110/integrated-bioinformatic-analysis-to-understand-the-association-between-phthalate-exposure-and-breast-cancer-progression
#10
JOURNAL ARTICLE
Nadeem G Khan, Sangavi Eswaran, Divya Adiga, S Sriharikrishnaa, Sanjiban Chakrabarty, Padmalatha S Rai, Shama Prasada Kabekkodu
Phthalates have been extensively used as plasticizers while manufacturing plastic-based consumer products. Estradiol mimicking properties and association studies suggest phthalates may contribute to breast cancer (BC). We performed an in-silico analysis and functional studies to understand the association between phthalate exposure and BC progression. Search for phthalate-responsive genes using the comparative toxicogenomics database identified 20 genes as commonly altered in response to multiple phthalates exposure...
November 1, 2022: Toxicology and Applied Pharmacology
https://read.qxmd.com/read/36297329/biocompatible-multi-mode-fluorescent-t-2-mri-contrast-magnetoelectric-silica-nanoparticles-magsins-for-on-demand-doxorubicin-delivery-to-metastatic-cancer-cells
#11
JOURNAL ARTICLE
Margo Waters, Juliane Hopf, Emma Tam, Stephanie Wallace, Jordan Chang, Zach Bennett, Hadrian Aquino, Ryan K Roeder, Paul Helquist, M Sharon Stack, Prakash D Nallathamby
There is a need to improve current cancer treatment regimens to reduce systemic toxicity, to positively impact the quality-of-life post-treatment. We hypothesized the negation of off-target toxicity of anthracyclines (e.g., Doxorubicin) by delivering Doxorubicin on magneto-electric silica nanoparticles (Dox-MagSiNs) to cancer cells. Dox-MagSiNs were completely biocompatible with all cell types and are therapeutically inert till the release of Doxorubicin from the MagSiNs at the cancer cells location. The MagSiNs themselves are comprised of biocompatible components with a magnetostrictive cobalt ferrite core (4-6 nm) surrounded by a piezoelectric fused silica shell of 1...
September 30, 2022: Pharmaceuticals
https://read.qxmd.com/read/36296712/phytochemical-composition-and-in-vitro-antioxidant-anti-inflammatory-anticancer-and-enzyme-inhibitory-activities-of-artemisia-nilagirica-c-b-clarke-pamp
#12
JOURNAL ARTICLE
Jawaher J Albaqami, Tancia P Benny, Hamida Hamdi, Ammar B Altemimi, Aswathi Moothakoottil Kuttithodi, Joice Tom Job, Anju Sasidharan, Arunaksharan Narayanankutty
Plants have been employed in therapeutic applications against various infectious and chronic diseases from ancient times. Various traditional medicines and folk systems have utilized numerous plants and plant products, which act as sources of drug candidates for modern medicine. Artemisia is a genus of the Asteraceae family with more than 500 species; however, many of these species are less explored for their biological efficacy, and several others are lacking scientific explanations for their uses. Artemisia nilagirica is a plant that is widely found in the Western Ghats, Kerala, India and is a prominent member of the genus...
October 21, 2022: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/36247681/synthesis-docking-studies-biological-activity-of-carbon-monoxide-release-molecules-based-on-coumarin-derivatives
#13
JOURNAL ARTICLE
Huapeng Liu, Yujie Chen, Fujun Cui, Yuan Liao, Xicun Wang
In the present work, we synthesized seven complexes. All complexes were identified by ESI-HRMS, 1 H-NMR, 19 F-NMR and 13 C-NMR spectroscopies. The synthesized complexes were tested for their anticancer activities in vitro against three different human cell lines, including breast MDAMB231, cervical Hela, liver HepG2. IC50 values of complexes 1-7 were 34.98-667.35 µM. Complex 5 revealed higher sensitivity towards MDAMB231 cells with IC50 values 34.98 μM in comparison to 5-FU as positive control. Moreover, complex 5 caused a decrease of mitochondrial membrane potential and effectively induced ROS production against MDAMB231 cells...
2022: Frontiers in Chemistry
https://read.qxmd.com/read/36216165/erk-activation-modulates-invasiveness-and-reactive-oxygen-species-ros-production-in-triple-negative-breast-cancer-cell-lines
#14
JOURNAL ARTICLE
Adilene Acosta-Casique, José B Montes-Alvarado, Minuet Barragán, Karen A Larrauri-Rodríguez, Andrea Perez-Gonzalez, Alam Delgado-Magallón, Lourdes Millán-Pérez-Peña, Nora H Rosas-Murrieta, Paola Maycotte
Triple negative breast cancer (TNBC) is the breast cancer subtype with the worst prognosis and still lacks a targeted therapy. In this study, we found increased ERK phosphorylation in TNBC cell lines and an important role for ERK in sustaining the migration of TNBC cells. Although ROS have been suggested to have an important role in sustaining MAPK signaling, antioxidant treatment increased ERK phosphorylation, probably suggesting increased invasive potential. Interestingly, treatment with PD0325901 (PD), a MEK inhibitor, decreased ROS levels in TNBC cells and decreased mitochondrial fragmentation in the MDAMB231 cell line...
October 7, 2022: Cellular Signalling
https://read.qxmd.com/read/35890160/design-and-anticancer-properties-of-new-water-soluble-ruthenium-cyclopentadienyl-complexes
#15
JOURNAL ARTICLE
Tânia S Morais, Fernanda Marques, Paulo J Amorim Madeira, Maria Paula Robalo, Maria Helena Garcia
Ruthenium complexes are emerging as one of the most promising classes of complexes for cancer therapy. However, their limited aqueous solubility may be the major limitation to their potential clinical application. In view and to contribute to the progress of this field, eight new water-soluble Ru(II) organometallic complexes of general formula [RuCp( m TPPMS)n (L)] [CF3 SO3 ], where m TPPMS = diphenylphosphane-benzene-3-sulfonate, for n = 2, L is an imidazole-based ligand (imidazole, 1-benzylimidazole, 1-butylimidazole, (1-(3-aminopropyl)imidazole), and (1-(4-methoxyphenyl)imidazole)), and for n = 1, L is a bidentate heteroaromatic ligand (2-benzoylpyridine, (di(2-pyridyl)ketone), and (1,2-(2-pyridyl)benzo-[b]thiophene)) were synthesized and characterized...
July 14, 2022: Pharmaceuticals
https://read.qxmd.com/read/35761360/inhibition-of-autophagy-by-chloroquine-prevents-resistance-to-pi3k-akt-inhibitors-and-potentiates-their-antitumor-effect-in-combination-with-paclitaxel-in-triple-negative-breast-cancer-models
#16
JOURNAL ARTICLE
Stefania Cocco, Alessandra Leone, Maria Serena Roca, Rita Lombardi, Michela Piezzo, Roberta Caputo, Chiara Ciardiello, Susan Costantini, Francesca Bruzzese, Maria José Sisalli, Alfredo Budillon, Michelino De Laurentiis
BACKGROUND: Triple negative breast cancer (TNBC) is an aggressive disease characterized by high risk of relapse and development of resistance to different chemotherapy agents. Several targeted therapies have been investigated in TNBC with modest results in clinical trials. Among these, PI3K/AKT inhibitors have been evaluated in addition to standard therapies, yielding conflicting results and making attempts on elucidating inherent mechanisms of resistance of great interest. Increasing evidences suggest that PI3K/AKT inhibitors can induce autophagy in different cancers...
June 27, 2022: Journal of Translational Medicine
https://read.qxmd.com/read/35723065/intercellular-adhesion-molecule-1-targeted-near-infrared-photoimmunotherapy-of-triple-negative-breast-cancer
#17
JOURNAL ARTICLE
Hiroshi Fukushima, Takuya Kato, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto, Shuhei Okuyama, Eisaku Kondo, Peter L Choyke, Hisataka Kobayashi
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, and conventional chemotherapy and molecular-targeted therapies show limited efficacy. Near-infrared photoimmunotherapy (NIR-PIT) is a new anticancer treatment that selectively damages the cell membrane of cancer cells based on NIR light-induced photochemical reactions of the antibody (Ab)-photoabsorber (IRDye700Dx) conjugate and the cell membrane. TNBC is known to express several adhesion molecules on the cell surface providing a potential new target for therapy...
September 2022: Cancer Science
https://read.qxmd.com/read/35555867/dmt1-mediated-endosome-mitochondria-interactions-regulates-iron-homeostasis-and-mitochondrial-metabolism
#18
JOURNAL ARTICLE
Jonathan Barra, Isaiah Crosbourne, Ling Wang, Iram Nelson, Joshua Goldwag, Frances Jourd'heuil, David Jourd'heuil, Margarida Barroso
Mitochondria-early endosome (EE) interactions have been shown to facilitate the translocation of iron into mitochondria. Here we show that Divalent Metal Transporter 1 (DMT1) modulates iron exit from endosomes and transport into mitochondria via regulation of EE-mitochondria interactions. In cancer cells, mitochondria are the ultimate cellular iron sink, where iron can be either stored or used for example to shift cellular metabolism towards glycolysis (Warburg effect), a key adaptive mechanism of cancer cells...
May 2022: FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology
https://read.qxmd.com/read/35316034/tracking-the-evolution-of-metastasis-with-self-functionalized-3d-nanoprobes
#19
JOURNAL ARTICLE
Rupa Haldavnekar, Akshay Venkatakrishnan, Amirkianoosh Kiani
Despite recent advances in cancer treatment, metastasis is the cause of mortality in 90% of cancer cases. It has now been well-established that dissemination of cancer cells to distant sites occurs very early during tumorigenesis, resulting in the minimal effect of surgical or chemotherapeutic treatments after the detection of metastasis. The underlying reason for this challenge is mostly due to the limited understanding of molecular mechanisms of the metastasis cascade, particularly related to metastatic traits...
April 18, 2022: ACS Applied Bio Materials
https://read.qxmd.com/read/34952283/trimethyl-chitosan-coated-palladium-nanoparticles-as-a-photothermal-agent-and-its-in-vitro-evaluation-in-2d-and-3d-model-of-breast-cancer-cells
#20
JOURNAL ARTICLE
Prachi Bangde, Tejal Pant, Ganesh Gaikwad, Ratnesh Jain, Prajakta Dandekar
The potential of palladium has been scantily explored in biomedical applications. In the present study, palladium nanoparticles (PdNPs) were synthesized and were successfully coated with trimethyl-chitosan (TMC) to improve their biocompatibility. Coating with TMC improved the nanoparticle accumulation in MDAMB231 breast cancer cells, compared to nanoparticles coated with native chitosan. The TMC coated palladium nanoparticles (TMC/PdNPs) exhibited good biocompatibility and physiological stability, as compared to the plain(uncoated) PdNPs...
March 2022: Colloids and Surfaces. B, Biointerfaces
keyword
keyword
109091
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.